NAFLD patients showed increased serum levels of antioxidant enzymes such as SOD, GPx, and GSH in an initial stage of NAFLD [62], indicating a possible adaptation mechanism to mild increase in oxidative stress (Figure 2). This evidence concerns the gene SOD1 and metabolic dysfunction-associated steatotic liver disease.